儿童撕裂伤修复的焦虑缓解:开放标签多中心适应性试验(ALICE)的统计分析计划
ALICE 试验是一项 III 期、贝叶斯、开放标签试验,旨在比较鼻内右美托咪定(IND)、鼻内咪达唑仑(INM)和吸入一氧化二氮(N2O)在儿童撕裂伤修复中减轻痛苦的最优药物。主要结局为观察性行为痛苦量表修订版(OSBD-R)评分,采用贝叶斯混合效应模型分析并计算为最优干预的概率(Pbest)。本文介绍该试验的统计分析计划,试验注册号 NCT05383495,注册日期 2022年5月16日。
要点
- ALICE 试验为 III 期、贝叶斯、开放标签试验,比较鼻内右美托咪定、鼻内咪达唑仑和吸入一氧化二氮三种药物。
- 主要结局为 OSBD-R 测量的痛苦,采用贝叶斯混合效应模型和数据驱动先验分布分析。
- 通过后验分布样本计算为最优干预的概率(Pbest)对干预进行排序。
核心结论
- ALICE 试验将为减少儿童撕裂伤修复相关痛苦的最有效药物提供证据。
研究设计与样本
- ALICE 试验是一项 III 期、贝叶斯、开放标签试验,比较鼻内右美托咪定(IND)、鼻内咪达唑仑(INM)和吸入一氧化二氮(N2O)。
- 试验注册号为 ClinicalTrials.gov NCT05383495,注册日期为 2022年5月16日。
- 本文为 ALICE 试验的统计分析计划,规定了结局指标与分析方法。
关键数值与推荐
- 主要结局痛苦采用观察性行为痛苦量表修订版(OSBD-R)测量。
- OSBD-R 评分采用贝叶斯混合效应模型分析,使用数据驱动先验分布。
- 利用模型后验分布样本计算为最优干预的概率(Pbest),对干预进行排序。
- 次要结局包括延迟适应不良行为、需要额外身体约束、不良事件和需要额外镇静。
- 试验将确定各治疗组达到充分镇静的相关成本。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laceration repairs are a common, yet distressing procedure in children. While a range of strategies is used to treat this distress, there is currently no standard of care. The Anxiolysis for Laceration Repair in Children (ALICE) trial aims to identify the most effective pharmacological agent to manage laceration repair-associated distress. This paper outlines the statistical analysis plan for the ALICE trial. The ALICE trial is a phase III, Bayesian, open-label trial that will identify the optimal agent for reducing distress among intranasal dexmedetomidine (IND), intranasal midazolam (INM), and inhaled nitrous oxide (N2O). The primary outcome, distress, will be measured by the Observational Scale of Behavioural Distress - Revised (OSBD-R). Scores from the OSBD-R will be analyzed using a Bayesian mixed effects model with data-driven prior distributions. Samples from the model's posterior distributions will be used to calculate the probability of being best statistic (Pbest), which will effectively rank the interventions. The trial will also evaluate delayed maladaptive behaviours, need for additional physical restraint, adverse events, and need for additional sedation as secondary outcomes. Furthermore, the trial will determine the costs associated with achieving adequate sedation in each treatment arm. DISCUSSION: This statistical analysis plan specifies the outcomes and analyses for the ALICE trial. The ALICE trial will provide evidence for the most effective agent for reducing distress in children receiving laceration repairs. TRIAL REGISTRATION: ClinicalTrials.gov NCT05383495. Registered on May 16, 2022.
引用
- Jiang A, Poonai N, Arthur-Hayward V, et al. Anxiolysis for laceration repair in children: statistical analysis plan for an open-label multicenter adaptive trial (ALICE). Trials. 2025. PMID: 40775649. doi:10.1186/s13063-025-09009-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。